XML 27 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock Compensation
6 Months Ended
Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Common Stock Compensation

(10) Common Stock Compensation

 

Stock Option Activity Summary

 

The Company’s stock option activity for the six months ended December 31, 2018, is as follows:

 

 

 

Shares

(in thousands)

 

 

Weighted Average

Exercise Price

 

Outstanding at June 30, 2018

 

 

361

 

 

$

5.48

 

Granted

 

 

 

 

 

 

Exercised

 

 

(3

)

 

 

2.25

 

Canceled or expired

 

 

(24

)

 

 

4.02

 

Outstanding at December 31, 2018

 

 

334

 

 

$

5.61

 

 

The aggregate intrinsic value of options exercisable at December 31, 2018, was $122 thousand as the fair value of the Company’s common stock is more than the exercise prices of these options. The remaining share-based compensation expense of $236 thousand related to stock options will be recognized over a weighted-average period of 1.36 years.

 

The table below details the Company’s stock options outstanding as of December 31, 2018:

 

Range of exercise prices

 

Number

Outstanding

 

 

Options

Outstanding

Weighted-

Average

Remaining

Contractual

Life (years)

 

 

Weighted-

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Options

Exercisable

Weighted-

Average

Exercise

Price

 

$1.60 – 3.55

 

 

78,500

 

 

 

3.13

 

 

$

3.21

 

 

 

78,500

 

 

$

3.21

 

$5.30 – 5.85

 

 

125,139

 

 

 

8.36

 

 

 

5.48

 

 

 

42,450

 

 

 

5.47

 

$6.00 – 8.35

 

 

130,000

 

 

 

5.89

 

 

 

7.19

 

 

 

86,000

 

 

 

6.59

 

$1.60 – 8.35

 

 

333,639

 

 

 

6.17

 

 

$

5.61

 

 

 

206,950

 

 

$

5.08

 

 

Compensation costs recognized related to stock option awards were $43 thousand and $67 thousand for the three months ended December 31, 2018, and 2017, respectively, and $84 thousand and $134 thousand for the six months ended December 31, 2018 and 2017, respectively.

 

Restricted Stock

 

The Company’s restricted stock activity for the six months ended December 31, 2018, is as follows:

 

 

 

Shares

(in thousands)

 

 

Weighted

Average

Grant-Date

Fair Value

 

Outstanding at June 30, 2018

 

 

28

 

 

$

10.16

 

Granted

 

 

199

 

 

 

3.40

 

Vested

 

 

(4

)

 

 

8.86

 

Canceled or expired

 

 

(5

)

 

 

9.58

 

Outstanding at December 31, 2018

 

 

218

 

 

$

4.03

 

 

Stock compensation expenses related to restricted stock were $19 thousand and $54 thousand for the three months ended December 31, 2018, and 2017, respectively, and $14 thousand and $108 thousand for the six months ended December 31, 2018 and 2017, respectively. The remaining share-based compensation expense of $710 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 2.89 years.